Midazolam + Drospirenone And Estradiol Interaction
Unknowninteraction on record
Description
Two further clinical drug-drug interaction studies using simvastatin and midazolam as marker substrates for CYP3A4, respectively, were performed and the results of these studies demonstrated that pharmacokinetics of the CYP3A4 substrates were not influenced by steady-state DRSP concentrations.
Source: FDA drug label - drospirenone and estradiol